Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination

The SARS-CoV-2 Omicron variant BA.2 sublineage is rapidly replacing earlier Omicron lineages, suggesting BA.2 has increased vaccine evasion properties. We measured neutralization titers of authentic BA.1 and BA.2 isolates in serum samples from persons who received the BNT162b2 booster vaccine. All...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Rune M. Pedersen, Line L. Bang, Lone W. Madsen, Thomas V. Sydenham, Isik S. Johansen, Thøger G. Jensen, Ulrik S. Justesen, Thomas E. Andersen
Médium: Artigo
Jazyk:Inglês
Vydáno: Centers for Disease Control and Prevention 2022-06-01
Edice:Emerging Infectious Diseases
Témata:
COVID-19
respiratory infections
severe acute respiratory syndrome coronavirus 2
SARS-CoV-2
SARS
coronavirus disease
On-line přístup:https://wwwnc.cdc.gov/eid/article/28/6/22-0503_article
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky